WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011014825) ANTIANGIOGENIC SMALL MOLECULES AND METHODS OF USE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/014825    International Application No.:    PCT/US2010/043998
Publication Date: 03.02.2011 International Filing Date: 30.07.2010
IPC:
A61K 31/343 (2006.01), A61K 31/435 (2006.01), A61K 31/519 (2006.01), A61P 35/00 (2006.01), A61P 19/02 (2006.01), A61P 17/06 (2006.01)
Applicants: THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES [US/US]; National Institutes Of Health Office Of Technology Transfer 6011 Executive Blvd., Suite 325 MSC 7660 Bethesda, MD 20892-7660 (US) (For All Designated States Except US).
ZUDAIRE, Enrique [ES/US]; (US) (For US Only).
APARICIO, Marta [ES/US]; (US) (For US Only).
CUTTITTA, Frank [US/US]; (US) (For US Only)
Inventors: ZUDAIRE, Enrique; (US).
APARICIO, Marta; (US).
CUTTITTA, Frank; (US)
Agent: HAMMER, Michael, D.; Klarquist Sparkman, LLP One World Trade Center Suite 1600 121 SW Salmon Street Portland, OR 97204 (US)
Priority Data:
61/230,667 31.07.2009 US
Title (EN) ANTIANGIOGENIC SMALL MOLECULES AND METHODS OF USE
(FR) PETITES MOLÉCULES ANTI-ANGIOGÉNIQUES ET PROCÉDÉS D'UTILISATION
Abstract: front page image
(EN)Methods of inhibiting undesired angiogenesis are provided, which methods include administering to a subject a therapeutically effective amount of at least one of the compounds described herein, or a pharmaceutically acceptable salt thereof.
(FR)La présente invention concerne des procédés permettant d'inhiber une angiogenèse non souhaitée, lesdits procédés consistant à administrer à un patient une quantité thérapeutiquement efficace d'au moins un des composés décrits ici, ou son sel pharmaceutiquement acceptable.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)